<DOC>
	<DOCNO>NCT00322907</DOCNO>
	<brief_summary>The purpose study assess safety efficacy Cotrifazid treat uncomplicated resistant malaria compare outcome mefloquine quinine+sulfadoxine/pyrimethamine ( SP )</brief_summary>
	<brief_title>Cotrifazid Safety Efficacy Against Malaria</brief_title>
	<detailed_description>Design : Open-label , block-randomised , comparative , multicentric trial . Setting : Four primary care health facility , two urban two rural area Madang East Sepik Province , Papua New Guinea . Participants : Patients age recurrent uncomplicated malaria Intervention : Random assignment receive either Cotrifazid , mefloquine standard treatment quinine+sulfadoxine/pyrimethamine ( SP ) . Outcome measure : Incidence clinical laboratory adverse event ; rate clinical and/or parasitological failure day 14</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Mefloquine</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Quinine</mesh_term>
	<mesh_term>Isoniazid</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<criteria>All subject &gt; 6 month age present centre diagnose malaria ( history fever , OptiMALÂ® test positive , major symptom ) already treat malaria 28 day , could include study , subject legal guardian ( child ) give inform consent clinician charge would give standard treatment resistant malaria independent study A subject include clinician prefer use quinine whatever reason , patient one symptom sign complicate severe malaria ( i.e . history recent convulsion , neurological sign impairment consciousness , heavy vomiting , haemoglobinuria , respiratory distress , bleeding , circulatory collapse , shock , jaundice , haemoglobin &lt; 5 g/dl ) , contraindication mefloquine ( history psychiatric disorder , epilepsy ) , pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 1999</verification_date>
	<keyword>malaria</keyword>
	<keyword>treatment</keyword>
	<keyword>cotrifazid</keyword>
	<keyword>clinical trial</keyword>
	<keyword>efficacy</keyword>
</DOC>